• Register
  • Login
    • en
    • ru
    • uz
  • en
  • ru
  • uz
Register Login
  • Current
  • Archives
    • About the Journal
    • Submissions
    • Editorial Masthead
    • Privacy Statement
    • Contact
Current Archives
About the Journal Submissions Editorial Masthead Privacy Statement Contact
  1. Home
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • MICROVASCULAR REMODELING AND THE ENDOTHELIAL-APOPTOTIC SWITCH IN LICHEN SCLEROSUS: AN IMMUNOHISTOCHEMICAL STAGE-BASED STUDY

    Omasharifa binti Jamal Po, Sidikov A.A.

    Purpose: To evaluate stage-specific microvascular and apoptotic changes in lichen sclerosus (LS) using CD31, VEGF and CD95 immunohistochemistry. Methods: The article is based on a dissertation cohort of 60 patients with LS. For stage-oriented immunohistochemical analysis, representative dermal samples from progressive-stage lesions (n=15) and chronic-stage lesions (n=15) were examined. Results: In progressive-stage LS, dermal CD31 expression was detected in 33% of samples, VEGF in 80%, and CD95 in 20%, while all three markers were absent in the epidermis. In chronic-stage LS, dermal CD31 expression was present in 53%, VEGF in 20%, and CD95 in 95% of samples, again with no epidermal expression. Morphologically, progressive-stage lesions showed vacuolar interface dermatitis, lymphocytic exocytosis and lichenoid inflammation, whereas chronic-stage lesions were dominated by papillary dermal fibrosis and sclerosis. Malignant progression to squamous cell carcinoma (SCC) was documented in 5 of 60 patients and was associated with ulceration, bleeding, proliferating irregular vessels, epithelial atypia, pathological mitoses and high CD95 expression. Conclusion: LS demonstrates a stage-dependent shift from endothelial activation and neoangiogenesis to endothelial injury, apoptotic remodeling and sclerosis. Combined clinicopathological and immunohistochemical assessment may improve early recognition of unfavorable disease evolution.

    72-75
    11-06-2026
    Read more
  • MICROVASCULAR REMODELING AND THE ENDOTHELIAL-APOPTOTIC SWITCH IN LICHEN SCLEROSUS: AN IMMUNOHISTOCHEMICAL STAGE-BASED STUDY

    Po O.J., Sidikov A.A.

    Purpose: To evaluate stage-specific microvascular and apoptotic changes in lichen sclerosus (LS) using CD31, VEGF and CD95 immunohistochemistry. Methods: The article is based on a dissertation cohort of 60 patients with LS. For stage-oriented immunohistochemical analysis, representative dermal samples from progressive-stage lesions (n=15) and chronic-stage lesions (n=15) were examined. Results: In progressive-stage LS, dermal CD31 expression was detected in 33% of samples, VEGF in 80%, and CD95 in 20%, while all three markers were absent in the epidermis. In chronic-stage LS, dermal CD31 expression was present in 53%, VEGF in 20%, and CD95 in 95% of samples, again with no epidermal expression. Morphologically, progressive-stage lesions showed vacuolar interface dermatitis, lymphocytic exocytosis and lichenoid inflammation, whereas chronic-stage lesions were dominated by papillary dermal fibrosis and sclerosis. Malignant progression to squamous cell carcinoma (SCC) was documented in 5 of 60 patients and was associated with ulceration, bleeding, proliferating irregular vessels, epithelial atypia, pathological mitoses and high CD95 expression. Conclusion: LS demonstrates a stage-dependent shift from endothelial activation and neoangiogenesis to endothelial injury, apoptotic remodeling and sclerosis. Combined clinicopathological and immunohistochemical assessment may improve early recognition of unfavorable disease evolution.

    40-43
    16-05-2026
    Read more
1 - 2 of 2 items

Information

  • For Readers
  • For Authors
  • For Librarians

Latest publications

  • Atom logo
  • RSS2 logo
  • RSS1 logo
TNMU Publishing

We bring together researchers, knowledge, and technology to accelerate medical progress and improve public health.

 

Navigation

Home
Journals
Conferences
To Authors
To Reviewers
Publishing services

Support

Guidelines for authors
Publication ethics
About us
FAQ
Feedback

Contacts

 
Uzbekistan, Tashkent,
Almazar District, Shifokorlar, 21
 
(+998) 91 164 24 40
 
publishing@tnmu.uz
© Copyright 2026 TNMU Publishing All Rights Reserved | Developed by in Science | Site create by in Designer
Login
Central Asian Journal of Medicine
Login
* Required
* Required
Forgot your password?
Keep me logged in
Register